Role of interferon gamma release assays in tuberculosis: Editorial

Respirology

Volumn 14, Issue 2, 2009, Pages 156-158

  Leung, Chi C ^a   Chang, Kwok C ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

BCG VACCINATION; CYTOKINE RELEASE; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 61349162325     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01470.x     Document Type: Editorial

References (14)

1. Centers for Diseases Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. CDC MMWR 2000 49 : No. RR-6.
2. World Health Organization. Laboratory-based Evaluation of 19 Commercially Available Rapid Diagnostic Tests for Tuberculosis (Diagnostic Evaluation Series No. 2). World Health Organization, Geneva, 2008.
3. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann. Intern. Med. 1987 107 : 837 42.
4. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004 364 : 2196 203.
5. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 2005 54 : 49 55.
6. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001 23 : 2017 21.
7. Canadian Tuberculosis Committee. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement. Can. Commun. Dis. Rep. 2008 34(ACS-6 1 13.
8. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 2008 149 : 177 84.
9. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005 365 : 1500 5.
10. Janssens JP, Roux-Lombard P, Perneger T, Metzger M, Vivien R et al. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur. Respir. J. 2007 30 : 722 8.
11. Kang YA, Lee HW, Hwang SS, Um SW, Han SK et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007 132 : 959 65.
12. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 2008 177 : 1164 70.
13. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE 2008 3 : e1379.
14. Bakir M, Millington K, Soysal A, Deeks JJ, Efee S et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann. Intern. Med. 2008 149 : 777 87.